Kevin Barton

5.2k total citations · 1 hit paper
50 papers, 3.2k citations indexed

About

Kevin Barton is a scholar working on Molecular Biology, Hematology and Genetics. According to data from OpenAlex, Kevin Barton has authored 50 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 17 papers in Hematology and 16 papers in Genetics. Recurrent topics in Kevin Barton's work include Acute Myeloid Leukemia Research (10 papers), Multiple Myeloma Research and Treatments (7 papers) and Glioma Diagnosis and Treatment (7 papers). Kevin Barton is often cited by papers focused on Acute Myeloid Leukemia Research (10 papers), Multiple Myeloma Research and Treatments (7 papers) and Glioma Diagnosis and Treatment (7 papers). Kevin Barton collaborates with scholars based in United States, Canada and China. Kevin Barton's co-authors include Jeffrey M. Leiden, Natarajan Muthusamy, Chao-Nan Ting, Min Lü, Cynthia Clendenin, Christopher Fischer, Emily Barr, Margaret Veselits, Chay T. Kuo and Serhan Alkan and has published in prestigious journals such as Nature, New England Journal of Medicine and Journal of Clinical Investigation.

In The Last Decade

Kevin Barton

47 papers receiving 3.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Transcription factor GATA-3 is required for development of the T-cell lineage

1996 516 citations Chao-Nan Ting, Kevin Barton et al. Nature profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kevin Barton United States	21	1.8k	1.0k	722	521	384	50	3.2k
Jeffrey L. Kutok United States	16	1.8k 1.0×	1.2k 1.2×	640 0.9×	735 1.4×	1.1k 2.8×	26	3.6k
Maria Luisa Sulis United States	19	2.2k 1.2×	399 0.4×	638 0.9×	764 1.5×	367 1.0×	52	3.2k
Mats Ehinger Sweden	30	1.5k 0.9×	426 0.4×	847 1.2×	796 1.5×	267 0.7×	86	3.2k
Stephan Teglund Sweden	15	2.0k 1.1×	1.1k 1.1×	1.8k 2.5×	386 0.7×	366 1.0×	23	3.9k
Gerwin Huls Netherlands	19	1.8k 1.0×	377 0.4×	844 1.2×	312 0.6×	200 0.5×	59	2.8k
Norihiko Kawamata Japan	38	2.2k 1.3×	467 0.5×	1.4k 1.9×	745 1.4×	588 1.5×	96	4.0k
Mark Lupher United States	27	1.6k 0.9×	1.3k 1.3×	596 0.8×	226 0.4×	218 0.6×	38	3.4k
G Vairo Australia	29	1.5k 0.9×	926 0.9×	1.3k 1.8×	476 0.9×	335 0.9×	49	2.8k
Silke Brüderlein Germany	30	1.5k 0.8×	746 0.7×	870 1.2×	152 0.3×	532 1.4×	65	3.5k
Olivier Albagli France	26	1.7k 1.0×	486 0.5×	361 0.5×	291 0.6×	213 0.6×	60	2.6k

Countries citing papers authored by Kevin Barton

Since Specialization

Citations

This map shows the geographic impact of Kevin Barton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kevin Barton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kevin Barton more than expected).

Fields of papers citing papers by Kevin Barton

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kevin Barton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kevin Barton. The network helps show where Kevin Barton may publish in the future.

Co-authorship network of co-authors of Kevin Barton

This figure shows the co-authorship network connecting the top 25 collaborators of Kevin Barton. A scholar is included among the top collaborators of Kevin Barton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kevin Barton. Kevin Barton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wang, Xiaoxin X., Kevin Barton, Komuraiah Myakala, et al.. (2025). Role of nuclear receptors, lipid metabolism, and mitochondrial function in the pathogenesis of diabetic kidney disease. American Journal of Physiology-Renal Physiology. 329(4). F510–F547. 3 indexed citations

Myakala, Komuraiah, Xiaoxin X. Wang, Nataliia V. Shults, et al.. (2025). The nonsteroidal MR antagonist finerenone reverses Western diet-induced kidney disease by regulating mitochondrial and lipid metabolism and inflammation. American Journal of Physiology-Renal Physiology. 329(5). F724–F743.

Huang, Jonathan, Miri Kim, Kristen L. Lauing, et al.. (2024). Age-stratified comorbid and pharmacologic analysis of patients with glioblastoma. Brain Behavior & Immunity - Health. 38. 100753–100753. 4 indexed citations

Prabhu, Michael C., et al.. (2023). EXTH-41. COMBINATION TREATMENT OF CALCIUM CHANNEL ANTAGONIST MIBEFRADIL ENHANCES THE EFFECT OF HYDROXYUREA AT THERAPEUTIC RANGES IN HIGH-GRADE MENINGIOMA IN VITRO. Neuro-Oncology. 25(Supplement_5). v233–v233. 1 indexed citations

Goyal, Abhishek, Vikram C. Prabhu, Anupama Chundury, et al.. (2023). PATH-04. TRANSFORMATION OF GRADE 2 OLIGODENDROGLIOMA TO GLIOSARCOMA WITH RAPID AND EXTENSIVE PROGRESSION: CASE REPORT.. Neuro-Oncology. 25(Supplement_5). v167–v167.

Lee, Jonathan, Rimas V. Lukas, Ignacio Jusué-Torres, et al.. (2023). MGMT Methylated High Grade Glioma with Distant Recurrence and Stable Original Tumor Site: Case Series. PubMed. 10(2). 2 indexed citations

Berg, Stephanie, Lei Zhang, Shanhui Liu, et al.. (2023). Active STAT3 Prevents Selinexor-Induced Caspase-Independent Apoptosis in Multiple Myeloma. Blood. 142(Supplement 1). 6611–6611. 1 indexed citations

Li, Yanchun, Christopher S. Seet, Kevin Barton, et al.. (2023). Distinct roles of hematopoietic cytokines in the regulation of leukemia stem cells in murine MLL-AF9 leukemia. Stem Cell Reports. 19(1). 100–111. 2 indexed citations

Zhang, Jiwang, et al.. (2022). High-risk disease in newly diagnosed multiple myeloma: beyond the R-ISS and IMWG definitions. Blood Cancer Journal. 12(5). 83–83. 41 indexed citations

10.

Rodby, Roger A., David Cimbaluk, Parameswaran Venugopal, et al.. (2019). When Monoclonal Gammopathy is of Renal Significance: A Case Study of Crystalglobulinemia From Chicago Multiple Myeloma Rounds. Clinical Lymphoma Myeloma & Leukemia. 19(6). e251–e258. 7 indexed citations

11.

Bahar, Burak, Kevin Barton, & Ameet R. Kini. (2016). The role of the Exon 13 G571S JAK2 mutation in myeloproliferative neoplasms. Leukemia Research Reports. 6. 27–28. 8 indexed citations

12.

Nand, Sucha, John E. Godwin, Scott E. Smith, et al.. (2008). Hydroxyurea, azacitidine and gemtuzumab ozogamicin therapy in patients with previously untreated non-M3 acute myeloid leukemia and high-risk myelodysplastic syndromes in the elderly: results from a pilot trial. Leukemia & lymphoma. 49(11). 2141–2147. 46 indexed citations

13.

Garcia, Tracey A., Rima M. Dafer, Sara E. Hocker, et al.. (2007). Recurrent Strokes in Two Patients With POEMS Syndrome and Castleman’s Disease. Journal of Stroke and Cerebrovascular Diseases. 16(6). 278–284. 18 indexed citations

14.

Geng, Yanbiao, Peter Laslo, Kevin Barton, & Chyung‐Ru Wang. (2005). Transcriptional Regulation of CD1D1 by Ets Family Transcription Factors. The Journal of Immunology. 175(2). 1022–1029. 32 indexed citations

15.

Ni, Hongyu, Melek Ergin, Qin Huang, et al.. (2001). Analysis of expression of nuclear factor κB (NF‐κB) in multiple myeloma: downregulation of NF‐κB induces apoptosis. British Journal of Haematology. 115(2). 279–286. 135 indexed citations

16.

Hettmann, Thore, Kevin Barton, & Jeffrey M. Leiden. (2000). Microphthalmia due to p53-mediated apoptosis of anterior lens epithelial cells in mice lacking the CREB-2 transcription factor. Developmental Biology. 222(1). 110–123. 117 indexed citations

17.

Sood, Rashmi, et al.. (1999). Forced expression of the leukemia-associated gene EVI1 in ES cells: a model for myeloid leukemia with 3q26 rearrangements. Leukemia. 13(11). 1639–1645. 60 indexed citations

18.

Barton, Kevin, Natarajan Muthusamy, Christopher Fischer, et al.. (1998). The Ets-1 Transcription Factor Is Required for the Development of Natural Killer Cells in Mice. Immunity. 9(4). 555–563. 295 indexed citations

19.

Kuo, Chay T., Margaret Veselits, Kevin Barton, et al.. (1997). The LKLF transcription factor is required for normal tunica media formation and blood vessel stabilization during murine embryogenesis. Genes & Development. 11(22). 2996–3006. 299 indexed citations

20.

Ting, Chao-Nan, et al.. (1996). Transcription factor GATA-3 is required for development of the T-cell lineage. Nature. 384(6608). 474–478. 516 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact